Zallaludeen Shafeek Salim, RN | |
1 Veterans Dr, Minneapolis, MN 55417-2309 | |
(612) 725-2000 | |
Not Available |
Full Name | Zallaludeen Shafeek Salim |
---|---|
Gender | Male |
Speciality | Registered Nurse |
Location | 1 Veterans Dr, Minneapolis, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821540121 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 326958 (New York) | Secondary |
163W00000X | Registered Nurse | 2478086 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Zallaludeen Shafeek Salim, RN 10335 106th St, Ozone Park, Ozone Park, NY 11417-1806 Ph: (718) 219-0936 | Zallaludeen Shafeek Salim, RN 1 Veterans Dr, Minneapolis, MN 55417-2309 Ph: (612) 725-2000 |
News Archive
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
Interplay between genes and the environment has been pondered at least since the phrase "nature versus nurture" was coined in the mid-1800s.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has requested through counsel that Trimeris consent to an extension of the expiration date of the tender offer for all of Trimeris' outstanding shares of common stock commenced by Arigene and the Purchaser on October 19, 2009. Arigene has requested an extension of the expiration date of the tender offer to January 15, 2010.
› Verified 2 days ago
Tiffanie J Woods, CPNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2530 Chicago Ave, Minneapolis, MN 55404 Phone: 612-874-1292 | |
Tiffany Woynilko, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Park Ave, Minneapolis, MN 55404 Phone: 612-343-3265 Fax: 612-343-3267 | |
Rachel Foss, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Park Ave, Minneapolis, MN 55404 Phone: 612-343-3265 Fax: 612-343-3267 | |
Amanda Carter, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1099 10th Ave Se, Minneapolis, MN 55414 Phone: 612-767-6272 | |
Andrew Richard Erickson, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 800 E 28th St, Minneapolis, MN 55407 Phone: 612-863-4000 | |
Tessa Somermeyer, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-625-4680 | |
Mr. Donald Michael Dunow, MSN, APRN, NP-C, CNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 401 Harding St Ne # 100, Minneapolis, MN 55413 Phone: 651-571-0000 Fax: 888-990-2714 |